Glycoengineering of NK Cells with Glycan Ligands of CD22 and Selectins for B‐Cell Lymphoma Therapy

Impact and Intricacies of Bone Marrow Microenvironment in B-cell Lymphomas: From Biology to Therapy

(2020) Anuvrat Sircar et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Glycoengineering of Natural Killer Cells with CD22 Ligands for Enhanced Anticancer Immunotherapy

(2020) Xianwu Wang et al.   ACS Central Science

Modulation of Target Antigen Density Improves CAR T Cell Functionality and Persistence

(2019) Sneha Ramakrishna et al.   CLINICAL CANCER RESEARCH

An Atlas of Human Glycosylation Pathways Enables Display of the Human Glycome by Gene Engineered Cells

(2019) Yoshiki Narimatsu et al.   MOLECULAR CELL

Bacterial glycosyltransferase-mediated cell-surface chemoenzymatic glycan modification

(2019) Senlian Hong et al.   Nature Communications

Acute Myeloid and Lymphoblastic Leukemia Cell Interactions with Endothelial Selectins: Critical Role of PSGL-1, CD44 and CD43

(2019) Caroline Spertini et al.   Cancers

Glycoengineering of chimeric antigen receptor (CAR) T-cells to enforce E-selectin binding

(2019) Nandini Mondal et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Sustained efficacy of adjuvant immunotherapy with cytokine-induced killer cells for hepatocellular carcinoma: an extended 5-year follow-up

(2018) Jeong-Hoon Lee et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Off-the-Shelf CAR-NK Cells for Cancer Immunotherapy

(2018) Elizabeth L. Siegler et al.   Cell Stem Cell

A Single-Step Chemoenzymatic Reaction for the Construction of Antibody–Cell Conjugates

(2018) Jie Li et al.   ACS Central Science

Exploiting CD22 on antigen-specific B cells to prevent allergy to the major peanut allergen Ara h 2

(2017) Kelly A. Orgel et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Human CD22 Inhibits Murine B Cell Receptor Activation in a Human CD22 Transgenic Mouse Model

(2017) Kyle J. Bednar et al.   JOURNAL OF IMMUNOLOGY

CD22 Ligands on a Natural N-Glycan Scaffold Efficiently Deliver Toxins to B-Lymphoma Cells

(2017) Wenjie Peng et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Expression system for structural and functional studies of human glycosylation enzymes

(2017) Kelley W Moremen et al.   Nature Chemical Biology

CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy

(2017) Terry J Fry et al.   NATURE MEDICINE

A phase I trial of NK-92 cells for refractory hematological malignancies relapsing after autologous hematopoietic cell transplantation shows safety and evidence of efficacy

(2017) Brent A. Williams et al.   Oncotarget

Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity

(2017) Congcong Zhang et al.   Frontiers in Immunology

Natural Killer Cell (NK-92MI)-Based Therapy for Pulmonary Metastasis of Anaplastic Thyroid Cancer in a Nude Mouse Model

(2017) Liya Zhu et al.   Frontiers in Immunology

Therapeutic Antibodies: What Have We Learnt from Targeting CD20 and Where Are We Going?

(2017) Michael J. E. Marshall et al.   Frontiers in Immunology

Sialic Acid Mimetics to Target the Sialic Acid–Siglec Axis

(2016) Christian Büll et al.   TRENDS IN BIOCHEMICAL SCIENCES

Natural Killer Cells for Immunotherapy – Advantages of the NK-92 Cell Line over Blood NK Cells

(2016) Hans Klingemann et al.   Frontiers in Immunology

NK-92: an ‘off-the-shelf therapeutic’ for adoptive natural killer cell-based cancer immunotherapy

(2015) Garnet Suck et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial

(2015) Daniel W Lee et al.   LANCET

Adoptive cell transfer as personalized immunotherapy for human cancer

(2015) S. A. Rosenberg et al.   SCIENCE

Cytokine-induced killer cells efficiently kill stem-like cancer cells of nasopharyngeal carcinoma via the NKG2D-ligands recognition

(2015) Fang Wei et al.   Oncotarget

Revving up Natural Killer Cells and Cytokine-Induced Killer Cells Against Hematological Malignancies

(2015) Gianfranco Pittari et al.   Frontiers in Immunology

The role of CD22 and Siglec-G in B-cell tolerance and autoimmune disease

(2014) Jennifer Müller et al.   Nature Reviews Rheumatology

On-Chip Synthesis and Screening of a Sialoside Library Yields a High Affinity Ligand for Siglec-7

(2013) Cory D. Rillahan et al.   ACS Chemical Biology

C-4 Modified Sialosides Enhance Binding to Siglec-2 (CD22): Towards Potent Siglec Inhibitors for Immunoglycotherapy

(2013) Sørge Kelm et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Cytokine-Induced Killer Cells Eradicate Bone and Soft-Tissue Sarcomas

(2013) D. Sangiolo et al.   CANCER RESEARCH

Synthesis of Biologically Active N- and O-Linked Glycans with Multisialylated Poly-N-acetyllactosamine Extensions Using P. damsela α2-6 Sialyltransferase

(2013) Corwin M. Nycholat et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Glyco-engineering 'super-self'

(2013) Matthew S Macauley et al.   Nature Chemical Biology

Maturing antibody–drug conjugate pipeline hits 30

(2013) Asher Mullard   NATURE REVIEWS DRUG DISCOVERY

Click and Pick: Identification of Sialoside Analogues for Siglec-Based Cell Targeting

(2012) Cory D. Rillahan et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Pasteurella multocida CMP-sialic acid synthetase and mutants of Neisseria meningitidis CMP-sialic acid synthetase with improved substrate promiscuity

(2011) Yanhong Li et al.   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

In vivo targeting of B-cell lymphoma with glycan ligands of CD22

(2010) W. C. Chen et al.   BLOOD

Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone

(2008) Robert Sackstein et al.   NATURE MEDICINE